[Hiring] Business Development Manager @LGC Group

Role Description

The Business Development Manager (CRO) will be instrumental in driving Axolabs’ sales in the US and Asia and in extending brand recognition within the associated client base. The successful candidate will draw on a sound scientific background in life sciences to deliver bespoke solutions to meet client requirements.

• Proactively engage with new and existing clients to close deals and forge alliances.
• Combine strong scientific skills with good business acumen.
• Report to the Director, Business Development, Kulmbach.
• Responsible for US/Asia business growth and achieving set targets.

Qualifications

• Significant experience within Pharmaceutical or CRO industries.
• Proven track record in deal making.
• Expertise in lead generation, visit management, customer account management, and relationship management with primarily USA-based clients.
• Successful business execution in Asia.
• Knowledge of the drug research and development process within the pharmaceutical industry.
• Knowledge in the Nucleic Acid Therapeutic area is preferred.

Requirements

• Prepare high quality proposals to meet client objectives that draw on the portfolio of skills and services available within the Axolabs organization.
• Represent Axolabs at industry conferences and scientific meetings.
• Identify and target new business opportunities.
• Effectively deliver customized presentations to prospective and existing clients that describe our value-added offerings.
• Build and maintain strong and trusted business relationships.
• Utilize the full suite of sales mechanisms to pitch capabilities and offerings to new or existing pharmaceutical and biotech clients.
• Deliver and report against set business targets.
• Ability to regularly travel within USA and Asia.

Benefits

• Compensation: USD 120,000 - USD 180,000 yearly.
• Work Arrangement: Remote.

Company Description

Axolabs specialises in a new class of drugs whose active ingredients are chemically derived from DNA or RNA. They are called oligonucleotide or nucleic acid therapeutics. We use our many years of expertise to help our clients make them a success. Some of these drugs have already been approved and are being used successfully against diseases that were previously untreatable in some cases. New drugs from this class are added every year.

We believe in Science for a Safer World and are currently seeking candidates who are up for the challenge of operating in a high-growth, purpose-driven organization. LGC Axolabs is located in Petaluma, US, Kulmbach and Berlin, Germany.